Published in Am J Physiol Heart Circ Physiol on February 19, 2010
Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front Genet (2012) 1.60
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med (2013) 1.12
MicroRNA miR-133b is essential for functional recovery after spinal cord injury in adult zebrafish. Eur J Neurosci (2011) 1.10
MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med Genomics (2012) 1.09
Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J Cell Biol (2012) 1.08
MicroRNAs in heart development. Curr Top Dev Biol (2012) 1.06
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes (2012) 1.01
Retracted A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J Biol Chem (2013) 1.00
MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells. J Biol Chem (2013) 0.96
Protein tyrosine phosphatase-like A regulates myoblast proliferation and differentiation through MyoG and the cell cycling signaling pathway. Mol Cell Biol (2011) 0.95
Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis. J Am Heart Assoc (2013) 0.87
Restriction of big hearts by a small RNA. Circ Res (2011) 0.87
Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1. FASEB J (2012) 0.87
Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease. World J Biol Chem (2015) 0.87
Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology. Int J Mol Sci (2013) 0.87
MicroRNAs and Cardiac Regeneration. Circ Res (2015) 0.86
Neurotensin--regulated miR-133α is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis. Gut (2014) 0.83
Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure. Cell Death Dis (2014) 0.82
MicroRNA-133α regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis. RNA Dis (2015) 0.81
An intragenic SRF-dependent regulatory motif directs cardiac-specific microRNA-1-1/133a-2 expression. PLoS One (2013) 0.78
Comparative Analyses of MicroRNA Microarrays during Cardiogenesis: Functional Perspectives. Microarrays (Basel) (2013) 0.77
Neurotensin-induced miR-133α expression regulates neurotensin receptor 1 recycling through its downstream target aftiphilin. Sci Rep (2016) 0.77
Choline protects against cardiac hypertrophy induced by increased after-load. Int J Biol Sci (2013) 0.76
RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion. Oncotarget (2016) 0.75
Methylation-mediated silencing of miR-124 facilitates chondrogenesis by targeting NFATc1 under hypoxic conditions. Am J Transl Res (2017) 0.75
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases. Front Med (Lausanne) (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
The functions of animal microRNAs. Nature (2004) 64.85
Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55
The role of site accessibility in microRNA target recognition. Nat Genet (2007) 18.52
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet (2005) 17.07
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (2007) 12.08
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol (1997) 11.57
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A (2006) 10.09
Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev (2003) 9.39
MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res (2007) 5.65
Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev (2008) 5.39
A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc (2007) 5.15
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol (2007) 4.65
The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature (1993) 4.26
MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev (2007) 4.01
miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res (2008) 3.96
Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol (2007) 3.67
Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell (2001) 3.37
Thermodynamics of RNA-RNA binding. Bioinformatics (2006) 3.10
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest (2004) 3.09
Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun (2004) 2.86
Retracted Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem (2008) 2.41
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res (2009) 2.40
Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Mol Cell Biol (2002) 2.30
Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science (1997) 2.25
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol (2009) 2.18
Retracted MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem (2007) 2.14
A similar DNA-binding motif in NFAT family proteins and the Rel homology region. J Biol Chem (1995) 1.70
PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Circ Res (2008) 1.66
Preload induces troponin I degradation independently of myocardial ischemia. Circulation (2001) 1.60
Ras regulates NFAT3 activity in cardiac myocytes. J Biol Chem (2000) 1.49
NFATc3 and NFATc4 are required for cardiac development and mitochondrial function. Circ Res (2003) 1.37
microRNAs put their signatures on the heart. Physiol Genomics (2007) 1.32
Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur J Heart Fail (2004) 1.08
PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. J Mol Cell Cardiol (2008) 1.03
Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway. Mol Cell Biochem (2008) 0.96
Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes. Cardiovasc Res (2004) 0.93
Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy. FEBS Lett (2007) 0.92
Expression of heat shock proteins in turtle and mammal hearts: relationship to anoxia tolerance. Am J Physiol Regul Integr Comp Physiol (2000) 0.89
14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J (2005) 0.86
Regulation of the stability and transcriptional activity of NFATc4 by ubiquitination. FEBS Lett (2008) 0.85
Regulation of polarized extension and planar cell polarity in the cochlea by the vertebrate PCP pathway. Nat Genet (2005) 2.36
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet (2011) 2.05
Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet (2012) 2.00
Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J (2006) 1.99
Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron (2002) 1.95
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet (2012) 1.64
Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. Biochem Biophys Res Commun (2003) 1.55
Cochlear gap junctions coassembled from Cx26 and 30 show faster intercellular Ca2+ signaling than homomeric counterparts. Am J Physiol Cell Physiol (2005) 1.49
Expression of Islet1 marks the sensory and neuronal lineages in the mammalian inner ear. J Comp Neurol (2004) 1.45
Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci U S A (2007) 1.44
Atoh1 directs the formation of sensory mosaics and induces cell proliferation in the postnatal mammalian cochlea in vivo. J Neurosci (2012) 1.43
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet (2011) 1.42
Surfactant-assisted sonochemical synthesis of hollow calcium silicate hydrate (CSH) microspheres for drug delivery. Ultrason Sonochem (2010) 1.39
Gap junction-mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions. Proc Natl Acad Sci U S A (2005) 1.39
Preparation and characterization of bioactive and biodegradable wollastonite/poly(D,L-lactic acid) composite scaffolds. J Mater Sci Mater Med (2004) 1.39
A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels. Laryngoscope (2006) 1.36
ROCK inhibitor Y-27632 suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells and increases their cloning efficiency. PLoS One (2011) 1.34
Targeted connexin26 ablation arrests postnatal development of the organ of Corti. Biochem Biophys Res Commun (2009) 1.32
Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Clin Cancer Res (2011) 1.30
Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population. Cancer Epidemiol Biomarkers Prev (2010) 1.29
A semi-floating gate transistor for low-voltage ultrafast memory and sensing operation. Science (2013) 1.28
MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun (2012) 1.28
Computing the viscosity of supercooled liquids. J Chem Phys (2009) 1.27
A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach. Genet Test Mol Biomarkers (2012) 1.26
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. Invest New Drugs (2014) 1.26
Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea. J Comp Neurol (2009) 1.25
The self-setting properties and in vitro bioactivity of tricalcium silicate. Biomaterials (2005) 1.20
Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models. Brain Res (2009) 1.20
Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic. Biomaterials (2005) 1.19
Gap junction mediated intercellular metabolite transfer in the cochlea is compromised in connexin30 null mice. PLoS One (2008) 1.16
Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release (2006) 1.16
Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials (2006) 1.15
In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials (2009) 1.15
Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J Cell Biochem (2005) 1.15
At what scale should microarray data be analyzed? Am J Pharmacogenomics (2004) 1.14
Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics. Biomaterials (2008) 1.11
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer (2011) 1.11
A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and beta-TCP ceramics. Biomaterials (2008) 1.10
Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31. Hum Genet (2008) 1.08
Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res (2011) 1.08
Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10. Am J Hum Genet (2004) 1.08
LIM-only protein, CRP2, switched on smooth muscle gene activity in adult cardiac myocytes. Proc Natl Acad Sci U S A (2006) 1.06
Expression patterns of aquaporins in the inner ear: evidence for concerted actions of multiple types of aquaporins to facilitate water transport in the cochlea. Hear Res (2002) 1.06
Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials (2011) 1.06
Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics. J Biomed Mater Res B Appl Biomater (2007) 1.06
Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum Mol Genet (2012) 1.05
Acid-sensing ion channel 2 contributes a major component to acid-evoked excitatory responses in spiral ganglion neurons and plays a role in noise susceptibility of mice. J Neurosci (2004) 1.05
Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. Nat Genet (2013) 1.04
Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics. Biomaterials (2013) 1.04
Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin Cancer Res (2013) 1.03
Effects of strontium in modified biomaterials. Acta Biomater (2010) 1.03
Characterization of Ca3SiO5/CaCl2 composite cement for dental application. Dent Mater (2007) 1.02
Electrospinning of three-dimensional nanofibrous tubes with controllable architectures. Nano Lett (2008) 1.02
Study on antibacterial effect of 45S5 Bioglass. J Mater Sci Mater Med (2008) 1.01
Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro. J Biomed Mater Res B Appl Biomater (2007) 1.01
Preparation of bone-like apatite-collagen nanocomposites by a biomimetic process with phosphorylated collagen. J Biomed Mater Res A (2008) 1.00
Fish oil enhances intestinal integrity and inhibits TLR4 and NOD2 signaling pathways in weaned pigs after LPS challenge. J Nutr (2012) 1.00
Liver trauma: experience in 348 cases. World J Surg (2003) 1.00
Connexin29 is highly expressed in cochlear Schwann cells, and it is required for the normal development and function of the auditory nerve of mice. J Neurosci (2006) 0.99
Deoxygedunin, a natural product with potent neurotrophic activity in mice. PLoS One (2010) 0.99
Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application. Interface Focus (2012) 0.98
Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles. Acta Biomater (2012) 0.97
Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis. Eur J Cancer (2012) 0.97
Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2. PLoS One (2012) 0.97
Aspirin selectively augmented N-methyl-D-aspartate types of glutamate responses in cultured spiral ganglion neurons of mice. Neurosci Lett (2003) 0.97
Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population. PLoS One (2013) 0.96
Ataxin 10 induces neuritogenesis via interaction with G-protein beta2 subunit. J Neurosci Res (2006) 0.96
Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds. Biomaterials (2004) 0.95
Protein tyrosine phosphatase-like A regulates myoblast proliferation and differentiation through MyoG and the cell cycling signaling pathway. Mol Cell Biol (2011) 0.95
The cementogenic differentiation of periodontal ligament cells via the activation of Wnt/β-catenin signalling pathway by Li+ ions released from bioactive scaffolds. Biomaterials (2012) 0.95
Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds. J Gene Med (2013) 0.95
Osteogenesis and angiogenesis induced by porous β-CaSiO(3)/PDLGA composite scaffold via activation of AMPK/ERK1/2 and PI3K/Akt pathways. Biomaterials (2012) 0.94
Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells. J Clin Invest (2013) 0.94
Discovery of potent, orally active benzimidazole glucagon receptor antagonists. Bioorg Med Chem Lett (2008) 0.94
Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. Biomaterials (2012) 0.94
In vitro bioactivity of akermanite ceramics. J Biomed Mater Res A (2006) 0.93
Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet (2013) 0.93
The cochlear pericytes. Microcirculation (2008) 0.93
The stimulation of osteogenic differentiation of human adipose-derived stem cells by ionic products from akermanite dissolution via activation of the ERK pathway. Biomaterials (2011) 0.92
A review of bioactive silicate ceramics. Biomed Mater (2013) 0.92
Effect of tricalcium silicate on the proliferation and odontogenic differentiation of human dental pulp cells. J Endod (2011) 0.92
Genetic deletion of Rnd3 results in aqueductal stenosis leading to hydrocephalus through up-regulation of Notch signaling. Proc Natl Acad Sci U S A (2013) 0.91
Delivery of dimethyloxallyl glycine in mesoporous bioactive glass scaffolds to improve angiogenesis and osteogenesis of human bone marrow stromal cells. Acta Biomater (2013) 0.91
Genetics of hearing and deafness. Anat Rec (Hoboken) (2012) 0.91
Study of serum interaction with a cationic nanoparticle: Implications for in vitro endocytosis, cytotoxicity and genotoxicity. Int J Pharm (2011) 0.91
Changes in gap junctional connexin isoforms during prostate cancer progression. Prostate (2006) 0.91
In vitro studies of novel CaO-SiO2-MgO system composite bioceramics. J Mater Sci Mater Med (2007) 0.91
Computing the viscosity of supercooled liquids: Markov Network model. PLoS One (2011) 0.90
Different functional consequences of two missense mutations in the GJB2 gene associated with non-syndromic hearing loss. Hum Mutat (2009) 0.90
Expression of sumoylation deficient Nkx2.5 mutant in Nkx2.5 haploinsufficient mice leads to congenital heart defects. PLoS One (2011) 0.90
Study on the self-setting property and the in vitro bioactivity of beta-Ca2SiO4. J Biomed Mater Res B Appl Biomater (2005) 0.90
Traumatic diaphragmatic rupture with combined thoracoabdominal injuries: Difference between penetrating and blunt injuries. Chin J Traumatol (2015) 0.89
Nkx2-8 downregulation promotes angiogenesis and activates NF-κB in esophageal cancer. Cancer Res (2013) 0.89
Proliferation and osteogenic differentiation of human periodontal ligament cells on akermanite and β-TCP bioceramics. Eur Cell Mater (2011) 0.89
Dietary arachidonate differentially alters desaturase-elongase pathway flux and gene expression in liver and intestine of suckling pigs. J Nutr (2011) 0.89
Establishment of a knock-in mouse model with the SLC26A4 c.919-2A>G mutation and characterization of its pathology. PLoS One (2011) 0.89